Aptamer Group announced on Tuesday that it has signed a new contract worth up to £0.62m with a top five global pharmaceutical ...

Aptamer Group Plc ( ($GB:APTA) ) has provided an update. Aptamer Group has secured a significant new contract with a top five pharmaceutical ...

Aptamer Group, which develops next-generation synthetic binders for the life sciences industry, has secured a new contract ...

The new £360,000 fee-for-service development contract is to develop Optimer® binders as targeted radiopharmaceuticals with ...

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday.

At times, aging doesn’t become evident in wrinkles or in gray hair, it occurs deep inside your body, in cells that have ceased to divide but are still alive. These “zombie cells,” or senescent cells ...

Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, announces the second phase of its on-going partnership with Neuro-Bio, an ...

Nanomedicine. 2013;8(6):983-993. Fan and coworkers reported novel multicolor fluorescent Apt–AuNPs for homogeneous detection of small-molecule targets. [45] First, the multicolor dye-labeled aptamers ...

CAGE Bio Inc., a clinical-stage biotechnology company pioneering novel immunomodulatory therapies for dermatological diseases ...